Nakashima, Shota, et al. “Development of Imatinibmesylate-Induced Interstitial Lung Disease 2 Weeks After Discontinuation of the Treatment: A Case Report”. Multidisciplinary Respiratory Medicine, vol. 7, Nov. 2012, https://doi.org/10.4081/mrm.2012.635.